Astragalosides IV inhibits high glucose-induced cell apoptosis through HGF activation in cultured human tubular epithelial cells

Renal Failure

Volumn 36, Issue 3, 2014, Pages 400-406

  Wang, Qin ^a   Shao, Xinghua ^a   Xu, Weijia ^a   Qi, Chaojun ^a   Gu, Leyi ^a   Ni, Zhaohui ^a   Mou, Shan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Astragalosides IV; Cell apoptosis; Hepatocyte growth factor; MAPK signaling pathway; Tubular epithelial cells

Indexed keywords

ASTRAGALOSIDE IV; CASPASE 3; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SCATTER FACTOR; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1; ASTRAGALOSIDE A; HERBACEOUS AGENT; SAPONIN; TRANSFORMING GROWTH FACTOR BETA; TRITERPENE;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; KIDNEY INJURY; KIDNEY TUBULE EPITHELIUM; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING; CELL CULTURE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; ENZYME ACTIVATION; EPITHELIUM CELL; KIDNEY PROXIMAL TUBULE; METABOLISM; PATHOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENZYME ACTIVATION; EPITHELIAL CELLS; GLUCOSE; HEPATOCYTE GROWTH FACTOR; HUMANS; KIDNEY TUBULES, PROXIMAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SAPONINS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRITERPENES;

EID: 84896473250     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.867798     Document Type: Article

References (21)

1. Renal Data System: USRDS 1998 Annual Data Report (NIH Publ. No. 98-3176). Washington, DC: US Government Printing Office; 1998.
2. Isermann B, Vinnikov IA, Madhusudhan T. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat Med. 2007;11:1349-1358.
3. Beyenbach KW. Kidneys sans glomeruli. Am J Physiol Renal Physiol. 2004;286:F811-F827.
4. Mou S, Wang Q, Shi B, et al. Hepatocyte growth factor ameliorates progression of interstitial injuries in tubular epithelial cells. Scand J Urol Nephrol. 2010;44:121-128.
5. Hei ZQ, Huang HQ, Zhang J, et al. Protective effect of Astragalus membranaceus on intestinal mucosa reperfusion injury after hemorrhagic shock in rats. World J Gastroenterol. 2005;11: 4986-4991.
6. Jia RZ, Jiang L, Qiao LX. Study on effct of radix astragali on injury of cerebral cortex in neonatal rats after hypoxia/ischemia brain damage. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005;25:54-57.
7. Ni ZH, Zhang QY, Qian JQ, et al. Effect of Astrgalin on matrix secretion and b1 integrin mRNA expression in human mesangial cells. Chin J Nephrol. 2000;16:303-307.
8. Xu YJ, Zhang QY, Lu M, et al. Effect of Astragulus membranaceus on expression of TGF-b in renal cortex of diabetic rats. Chin J Endocrinol Metab. 1998;14:312-314.
9. Sheridan AM. Renal mouse proximal tubular cells are more susceptible than MDCK cells to chemical anoxia. Am J Physiol. 1993;265:F342-F350.
10. Ichimura T, Bonventre JV, Bailly V, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem. 1998;273:4135-4142.
11. Border WA, Noble NA. Interactions of transforming growth factorb and angiotensin II in renal fibrosis. Hypertension. 1998;31: 181-188.
12. Dai C, Liu Y. Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J Am Soc Nephrol. 2004;15: 1402-1412.
13. Liu ZQ, Li QZ, Qin GJ. Effect of Astragalus injection on platelet function and plasma endothelin in patients with early stage diabetic nephropathy. Chin J Integr Tradit West Med. 2001; 21:274-276.
14. Yang R, Ni ZH, Qian JQ, et al. The significance of big-h3 expression in renal tissue of diabetic rats and the efects oflosartan and astragalus memberaneous. Chin J Nephrol. 2004; 10:347-350.
15. Liu Y. Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol. 2004;287:F7-F16.
16. Mizuno S, Nakamura T. Suppressions of chronic glomerular injuries and TGF-b1 production by HGF in attenuation of murine diabetic nephropathy. Am J Physiol Renal Physiol. 2004;55:F134- F143.
17. Taniyama Y, Morishita R, Nakagami H, et al. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation. 2000;102:246-252.
18. Coltella N, Rasola A, Nano E. p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. Int J Cancer. 2006;118: 2981-2990.
19. Liu HT, He JL, Li WM, et al. Geniposide inhibits interleukin-6 and interleukin-8 production in lipopolysaccharide-induced human umbilical vein endothelial cells by blocking p38 and ERK1/2 signaling pathways. Inflamm Res. 2010;59:451-461.
20. Yuan W, Zhang Y, Ge Y, et al. Astragaloside IV inhibits proliferation and promotes apoptosis in rat vascular smooth muscle cells under high glucose concentration in vitro. Planta Med. 2008;74:1259-1264.
21. Huang XP, Liu XD, Deng CQ. Effects of the combination of active component extracts from Astragalus membranaceus and Panax notoginseng on apoptosis, reactive oxygen species and mitochondrial membrane potential of PC12 cells with oxidative injury. J Chin Integr Med. 2012;10:1127-1134.